Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
303.53
-4.29 (-1.39%)
At close: Oct 23, 2026, 4:00 PM EDT
303.53
0.00 (0.00%)
After-hours: Oct 23, 2026, 5:09 PM EDT
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 47 employees as of December 31, 2025. The number of employees decreased by 21 or 30.88% compared to the previous year. That makes Ligand Pharmaceuticals the 35,324th largest employer in the world and 4,739th in the United States.
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$6,181,745
Profits / Employee
$4,196,170
Market Cap
6.05B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -21 | -30.88% |
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Mirum Pharmaceuticals | 433 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 315 |
| Cogent Biosciences | 258 |
| Praxis Precision Medicines | 168 |
| CG Oncology | 142 |
| Kodiak Sciences | 141 |
LGND News
- 1 day ago - Ligand to Host Investor Day on December 8, 2026 - GlobeNewsWire
- 4 days ago - Ligand price target raised to $406 from $388 at BofA - TheFly
- 8 days ago - Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 - GlobeNewsWire
- 4 weeks ago - Ligand initiated with an Overweight at Barclays - TheFly
- 4 weeks ago - Wainwright sees upside in Ligand after new CAR-T investment in AvenCell - TheFly
- 4 weeks ago - Ligand enters financing agreement with AvenCell for up to $47M - TheFly
- 4 weeks ago - Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million - GlobeNewsWire
- 4 weeks ago - Ligand price target raised to $397 from $390 at Citi - TheFly